Connor, Clark & Lunn Investment Management (CC&L)’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
319,066
-40,511
| -11% | -$138K | ﹤0.01% | 1025 |
|
|
2025
Q1 | $1.44M | Sell |
359,577
-242,118
| -40% | -$971K | 0.01% | 827 |
|
|
2024
Q4 | $3.91M | Sell |
601,695
-13,935
| -2% | -$90.4K | 0.02% | 552 |
|
|
2024
Q3 | $3.41M | Sell |
615,630
-15,842
| -3% | -$87.8K | 0.02% | 538 |
|
|
2024
Q2 | $3.52M | Sell |
631,472
-486
| -0.1% | -$2.71K | 0.01% | 513 |
|
|
2024
Q1 | $4.24M | Buy |
631,958
+107,245
| +20% | +$720K | 0.02% | 470 |
|
|
2023
Q4 | $4.79M | Buy |
524,713
+296,318
| +130% | +$2.7M | 0.02% | 433 |
|
|
2023
Q3 | $1.26M | Buy |
+228,395
| New | +$1.26M | 0.01% | 746 |
|